Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M M Morris-Downes

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Gene Therapy|September 23, 2000
Inhibition of human lung carcinoma cell growth by apoptosis induction using Semliki Forest virus recombinant particlesA M Murphy, M M Morris-Downes, B J Sheahan, et al.
Clinical and Experimental Immunology|December 21, 2000
The protective effects of omega-6 fatty acids in experimental autoimmune encephalomyelitis (EAE) in relation to transforming growth factor-beta 1 (TGF-beta1) up-regulation and increased prostaglandin E2 (PGE2) productionL S Harbige, L Layward, M M Morris-Downes, et al.
Vaccine|June 28, 2001
A recombinant Semliki Forest virus particle vaccine encoding the prME and NS1 proteins of louping ill virus is effective in a sheep challenge modelM M Morris-Downes, B J Sheahan, M N Fleeton, et al.
Reviews in Medical Virology|October 4, 2000
Transient virus infection and multiple sclerosisG J Atkins, S McQuaid, M M Morris-Downes, et al.
Vaccine|March 3, 2001
Semliki Forest virus-based vaccines: persistence, distribution and pathological analysis in two animal systemsM M Morris-Downes, K V Phenix, J Smyth, et al.
The Journal of Hospital Infection|August 23, 2011
A 12-year review of Staphylococcus aureus bloodstream infections in haemodialysis patients: more work to be doneS F Fitzgerald, J O'Gorman, M M Morris-Downes, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|December 11, 2012
Secular trends in nosocomial bloodstream infections: antibiotic-resistant bacteria increase the total burden of infectionH S M Ammerlaan, S Harbarth, A G M Buiting, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Gene Therapy|September 23, 2000
Inhibition of human lung carcinoma cell growth by apoptosis induction using Semliki Forest virus recombinant particlesA M Murphy, M M Morris-Downes, B J Sheahan, et al.
Clinical and Experimental Immunology|December 21, 2000
The protective effects of omega-6 fatty acids in experimental autoimmune encephalomyelitis (EAE) in relation to transforming growth factor-beta 1 (TGF-beta1) up-regulation and increased prostaglandin E2 (PGE2) productionL S Harbige, L Layward, M M Morris-Downes, et al.
Vaccine|June 28, 2001
A recombinant Semliki Forest virus particle vaccine encoding the prME and NS1 proteins of louping ill virus is effective in a sheep challenge modelM M Morris-Downes, B J Sheahan, M N Fleeton, et al.
Reviews in Medical Virology|October 4, 2000
Transient virus infection and multiple sclerosisG J Atkins, S McQuaid, M M Morris-Downes, et al.
Vaccine|March 3, 2001
Semliki Forest virus-based vaccines: persistence, distribution and pathological analysis in two animal systemsM M Morris-Downes, K V Phenix, J Smyth, et al.
The Journal of Hospital Infection|August 23, 2011
A 12-year review of Staphylococcus aureus bloodstream infections in haemodialysis patients: more work to be doneS F Fitzgerald, J O'Gorman, M M Morris-Downes, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|December 11, 2012
Secular trends in nosocomial bloodstream infections: antibiotic-resistant bacteria increase the total burden of infectionH S M Ammerlaan, S Harbarth, A G M Buiting, et al.
Pageof 1